Guru KrishnaKumar Viswanathan

Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model

Guru KrishnaKumar Viswanathan, Dana Shwartz, Yelena Losev et al. · Cellular and Molecular Life Sciences · 2019 · 62 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Alzheimer's Disease +13

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration

Yelena Losev, Moran Frenkel‐Pinter, Malak Abu-Hussien et al. · Cellular and Molecular Life Sciences · 2020 · 50 citations · Full text

Glycoproteomics, Neurodegenerative Diseases, Molecular Neuroscience +12

Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer’s Disease and Type-2 Diabetes

Ashim Paul, Guru KrishnaKumar Viswanathan, Satabdee Mahapatra et al. · ACS Chemical Neuroscience · 2019 · 35 citations

Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone–Dopamine hybrid

Ashim Paul, Guru KrishnaKumar Viswanathan, Adi Huber et al. · FEBS Journal · 2021 · 25 citations · Full text

Tryptophan–glucosamine conjugates modulate tau-derived PHF6 aggregation at low concentrations

Ashim Paul, Wenhao Li, Guru KrishnaKumar Viswanathan et al. · Chemical Communications · 2019 · 17 citations

Protein Chemistry, Amyloidogenic Proteins, Protein Assembly +12